According to the NFATP guidelines, the baseline evaluation including CD4 cell count, complete blood count, transaminase levels, TB test, and serologic test for HBV and HCV should be performed before the initiation of combined antiretroviral therapy (cART). This evidence concerns the gene CD4 and tuberculosis.